Physician-scientists from Cedars-Sinai Cancer will present research and are available for comment on breaking news throughout the American Society of Hematology Annual Meeting & Exposition taking place Dec. 10-13 in New Orleans.
Physician-scientists from Cedars-Sinai Cancer are available for comment on research being presented throughout the San Antonio Breast Cancer Symposium, taking place Dec. 6-10.
Cedars-Sinai Pharmacy experts will present their latest advances in research and care in person at the midyear clinical meeting of the American Society of Health-System Pharmacists (ASHP) in Las Vegas Dec. 4-8, sharing innovations to improve medication safety, availability and effectiveness for hospital patients.
Bert Mandelbaum, MD, medical director of the FIFA Medical Center of Excellence, Cedars-Sinai Kerlan-Jobe Institute, and associate chief medical officer of Major League Soccer, has been providing medical care to the U.S men’s national soccer team for nearly three decades.
Experts from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available for interviews and to comment on research being presented at the conference.
This holiday season, millions of people will be celebrating with family and friends. Preparing and sharing food is often the centerpiece of getting together. However, while good cheer may fill the air, danger could be lurking just beyond the door to the kitchen or dining room.
Diabetes is a chronic health condition that impacts how the body turns food into energy. More than 37 million people in the United States have Type 2 diabetes, the most common form of the metabolic disorder, according to the Centers for Disease Control and Prevention. An additional 96 million adults have prediabetes and most of them are unaware they are developing a serious chronic disease.
November is Pancreatic Cancer Awareness Month as well as National Lung Cancer Awareness Month, and experts from Cedars-Sinai Cancer are available to discuss the newest research and treatment options.
Neuroscientists from Cedars-Sinai will present—and are available to comment on—cutting-edge brain research at the sixth International Human Single Neuron Meeting Nov. 10-11 at UCLA, and Neuroscience 2022, the annual meeting of the Society for Neuroscience, Nov. 12-16 in San Diego.
Cedars-Sinai and other hospitals nationwide are seeing a surge in cases of pediatric RSV (respiratory syncytial virus) that are showing up earlier than expected this year. Healthcare providers are worried about the onset of the virus combined with the additional threats of the flu and COVID-19 as we head into winter.
Although breast cancer is more common in women, during October, Breast Cancer Awareness Month, experts from Cedars-Sinai Cancer are reminding men that they are at risk as well. One in every 100 breast cancers in the U.S. is diagnosed in a man, according to the Centers for Disease Control and Prevention.
Cedars-Sinai physicians and scientists will share the results of new research aimed at improving the treatment of digestive diseases during the international meeting of the American College of Gastroenterology (ACG). The clinical conference will take place Oct. 21-26 in Charlotte, North Carolina, and is available for virtual and in-person attendance.
Cedars-Sinai Orthopaedic Trauma experts will present their latest advances in treatments and research at the annual meeting of the Orthopaedic Trauma Association (OTA) in Florida Oct. 12-15.
Cedars-Sinai Guerin Children’s pediatric specialists will share their expertise and recent research findings at the American Academy of Pediatrics Annual Meeting, taking place Oct. 7-11 in Anaheim, California.
As Breast Cancer Awareness Month begins, Cedars-Sinai Cancer experts are available to discuss new treatments for breast cancer patients and the innovative ways Cedars-Sinai Cancer is making those treatments accessible to all.
As Southern California endures the ongoing heatwave, Southern California Sam Torbati, MD, is available later today and throughout the holiday weekend to discuss how to avoid hot weather emergencies.
While the Los Angeles Rams quarterback Matthew Stafford works on his timing in the pocket, sports medicine specialists from Cedars-Sinai Kerlan-Kobe Institute—renowned for treating today's top professional athletes—are going through their reps to keep players healthy as they prepare to defend their championship title. Cedars-Sinai Kerlan-Jobe Institute specialists serve as the official team physicians for the Rams.
During National Atrial Fibrillation (AFib) Awareness Month and Aortic Disease Awareness Week, Smidt Heart Institute cardiologists and surgeons are available for interviews with journalists working on stories about these common heart conditions.
Monkeypox cases are on the rise in the U.S., stoking fear and confusion about the way the virus is spread, who is at risk and where to seek treatment.
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research—including late-breaking science—during the European Society of Cardiology Congress 2022, taking place in person and virtually Aug. 26-29.
When it comes to COVID-19 immunity, antibodies do not tell the whole story, according to Cedars-Sinai professor of Medicine Stanley C. Jordan, MD.
Physician-scientists from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available for media interviews during the Alzheimer’s Association International Conference (AAIC) taking place online and in person July 31-Aug. 4, 2022, in San Diego.
Experts from Cedars-Sinai Cancer are available to comment on the American Association for Cancer Research (AACR) Cancer Disparities Progress Report 2022, which will be released Wednesday, June 8, in a virtual congressional briefing. The report highlights the need to increase diversity in clinical trials and the cancer workforce, and it provides policy recommendations for addressing cancer disparities—all areas Cedars-Sinai Cancer is working to address.
Cedars-Sinai clinicians and scientists, including anti-rejection therapy pioneer Stanley Jordan, MD, will share their latest advances in research at the American Transplant Congress (ATC), June 4-8, 2022, in Boston. The ATC is the joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.
Physicians and scientists from Cedars-Sinai will discuss the latest advances in treatment, care and research at the Endocrine Society’s annual meeting (ENDO 2022) in Atlanta, June 11-14.
Multiple cases of monkeypox have surfaced in Europe and the U.S. that do not appear to be linked to travel, causing concern among the medical community that this infectious disease is spreading through sexual contact or other close interactions.
Studies have shown that the way LGBTQ+ patients are screened, diagnosed and treated for cancer may put them at a significant disadvantage compared to cisgender heterosexual patients.
There's a huge urgency worldwide to find new therapies that help patients with amyotrophic lateral sclerosis (ALS), a fatal neurological disorder that causes people to eventually lose the ability to walk, talk, eat and breathe. In recognition of ALS Awareness Month, Dr. Deepti Lall shares why she’s optimistic about scientific advances for this fatal disease
More than 300 oral and poster presentations from the nation’s experts in gynecological and obstetrical health will be shared at the Annual Clinical and Scientific Meeting of the American College of Obstetricians & Gynecologists (ACOG ACSM). The conference takes place in San Diego from May 6-8.
Today, the Food and Drug Administration (FDA) announced the approval of mavacamten, a new drug shown to provide relief to obstructive hypertrophic cardiomyopathy patients experiencing shortness of breath.
Cardiologists and cardiothoracic surgeons from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care, transcatheter procedures and cardiothoracic surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2022 and Heart Rhythm 2022.
Physician-scientists from the Smidt Heart Institute at Cedars-Sinai are working to identify genetic risk factors for cardiomyopathy—a collection of conditions that reduce the heart’s ability to pump blood to the rest of the body—and how inherited forms of the condition can be detected at earlier stages.
Throughout the month of April—Donate Life Month—experts from Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute are available for interviews on issues related to transplantation, immunology and organ donation.
Michelle Kittleson, MD, PhD, Director of Post-Graduate Education in Heart Failure and Transplantation and Director of Heart Failure Research in the Smidt Heart Institute, Can Discuss New Clinical Guidance
Cedars-Sinai’s newest department, Computational Biomedicine, is up and running, giving the Cedars-Sinai Newsroom an opportunity to speak with the department’s founding chair, Jason H. Moore, about the history of this relatively new field, how to mine big data and the future of artificial intelligence in healthcare.
Cedars-Sinai Cancer experts will present their latest advances in treatments and research at the American Association for Clinical Research (AACR) Annual Meeting 2022 in New Orleans, April 8-13. They will share their innovations to improve the quality of patient care.
Cedars-Sinai neurology experts are available to discuss the latest advances in research and clinical care for patients with disorders of the nervous system ahead of the 74th annual meeting of the American Academy of Neurology (AAN), happening April 2-7.
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research data and lead discussions on medical breakthroughs during the American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place in person and virtually April 2-4.
As mask mandates disappear across the U.S., many are eager to return to pre-pandemic life. But scientists warn against letting down our guard too soon, pointing out that new variants could arise in the months ahead.
The brain is front and center during March, and experts from the Cedars-Sinai departments of Neurology & Neurosurgery are available for interviews about the latest research and treatments for neurological diseases and conditions, including multiple sclerosis, epilepsy and traumatic brain injuries.
There are no ifs, ands or “butts” about it: March is Colorectal Cancer Awareness Month and a timely reminder to get screened for one of the deadliest—and most preventable—cancers.
Cancer treatments save lives. They also might cause heart damage in the process. Cedars-Sinai research scientist Arun Sharma, PhD, wants to be able to predict when this might happen, and is creating models of the human heart by using stem cells derived from blood. The goal is to better personalize cancer treatments.
Cardiothoracic surgeons in the Smidt Heart Institute at Cedars-Sinai recently performed a groundbreaking robotic-assisted lung transplant.
Throughout the month of February—American Heart Month—the Cedars-Sinai Newsroom will highlight new research, heart-health recommendations and clinical and surgical advances. Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top heart and heart surgery programs, are available to address these timely heart-related topics.
Following Medicare’s decision today about paying for a new Alzheimer’s disease treatment only in limited circumstances, Zaldy Tan, MD, MPH, a highly respected memory and geriatric medicine specialist at Cedars-Sinai, is available to comment.
As the highly contagious omicron variant surges COVID-19 cases to record highs, some are wondering if they should intentionally get the virus in the hope of developing immunity.
First on the list: Get vaccinated and get a booster shot if you qualify.
Zahn, a professor of pediatrics and the director of the Guerin Family Congenital Heart Program in the Smidt Heart Institute, was the principal investigator for the multicenter clinical trial which led to the FDA's approval today. He says the new device will allow interventional cardiologists to treat more patients.
As the first cases of flu are reported in Los Angeles this season, public health experts are urging anyone who isn't already vaccinated to get the flu shot. It's the best protection against the flu, which could pummel the U.S. this winter after nearly disappearing last year.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
